Join the MAPS Med Tech FAWG as they discuss “Medical Affairs Mastery: Shaping the Future of MedTech with MAPS”!
Danie du Plessis, Chair of the MAPS Board of Directors, speaks with HSTalks about the MAPS organization and Medical Affairs leadership.
The MAPS Executive Consortium details how Medical Affairs will drive the evolution of industry to match the needs of a changing society.
The combined impact of treatment complexity and data availability highlights the value of Medical Affairs departments that have the capability to make clinical sense of new disruptive drugs, devices, real-time monitoring and diagnostics. Here, the MAPS Executive Consortium describes how.
This paper provides a vision describing how Gen AI technologies will reshape the possibilities and practice of Medical Affairs related to the four functional pillars of Strategy & Leadership, Evidence & Insights Generation, Evidence & Insights Communication, and Engagement & Partnerships.
In this episode, Ariel Katz, co-Founder and CEO of H1, provides a more linear and streamlined vision for how Medical Affairs can impact patient outcomes — and how to measure the results of our actions.
This White Paper draws on the expertise of 10 senior Medical Affairs leaders across diverse global organizations to describe the role of Medical Affairs in ensuring the MedTech industry meets the challenges of high-quality evidence, objective measures, changes in the healthcare landscape, and more.
In today’s episode, we’ll be looking at considerations for Medical Affairs in Rare Disease and Gene Therapy
In this webinar, we will discover how Medical Affairs teams are evolving from an executional hub to a strategic pillar, resonating and reconciling the voice of the patient and clinicians, and driving insights to their organization.
In this webinar, a roundtable of experienced Medical Affairs leaders will discuss the opportunities and challenges evolving within their field, as well as the impact it can have on delivering great patient outcomes.